Latest Uk Market News

TechnologyOne has reported a robust FY25 with profit before tax up 19% and ARR reaching $554.6 million, propelled by its SaaS+ platform and UK market expansion. The company sets an ambitious $1 billion ARR target by FY30, underpinned by strong R&D investment and AI integration.

TechnologyOne has delivered a standout FY25 performance, beating profit guidance and accelerating its ARR growth well ahead of schedule, powered by its innovative SaaS+ model and strong UK market traction.

Airtasker has raised $10 million in a strategic equity placement led by iHeartMedia, aiming to accelerate its growth in the US and UK markets through targeted marketing and expanded media partnerships.

Bioxyne Limited is expanding its footprint with a new UK GMP-certified medicinal cannabis manufacturing site, backed by £850,000 in funding from South of Scotland Enterprise. This move positions the company to tap into the UK’s growing medicinal cannabis market, the second largest in Europe.

Etherstack plc reports a record-breaking FY25 with revenues up 62%, driven by major US and UK contracts, and projects continued strong growth into FY26 and beyond.

RAS Technology Holdings has landed a significant contract to provide racing data and managed trading services for LeoVegas Group’s UK brands, including BetMGM UK, marking a strategic expansion into regulated markets.

PEXA Group reported a robust first quarter for FY26, driven by refinancing growth in Australia and rising momentum in the UK market. The company reaffirmed its full-year guidance while advancing key strategic initiatives including platform modernization and a NatWest partnership.

HITIQ Ltd has secured a landmark order for its PROTEQT™ mouthguards at the Winter Olympics and launched in the UK consumer market, while advancing global validation and raising over A$2 million in capital.

GWA reported modest revenue and earnings growth in FY25, driven by strong performance in Australia and the UK despite a tough New Zealand market. The company also initiated a $30 million on-market share buyback and increased its fully franked dividend.

Control Bionics reports a strong start to FY26 with nearly 10% revenue growth, expanded US reimbursement coverage, and advancing commercialization of its NeuroNode and NeuroStrip technologies.

Cycliq Group has completed a major e-commerce platform upgrade while preparing inventory for the critical Cyber November sales, reporting a 35% drop in quarterly customer receipts as it invests in future growth.

Microba Life Sciences reports a 145% jump in core microbiome test volumes and is on track to achieve regional break-even by FY26, supported by strategic cost cuts and a $14.5 million capital raise.